In the healthcare sector the elderly are often overlooked. Luckily an organization like Sussex Healthcare exists. Sussex has been providing specialized care to the elderly for well over two decades. While Sussex does provide services for other adults it primarily focuses on senior citizens.
Sussex has benefited greatly from the complimenting skills of its two chairmen, Shiraz Boghani and Shafik Sachedina. Boghani has a background as a hotel manager and Sachedina, a former dental surgeon, has experience in the medical field. The combination of the two professionals has led to Sussex Healthcare being one of the premiere adult care networks in the world.
Sussex was founded more than 25 years ago opening its first facility in 1985. Since then Sussex has vastly expanded boasting more than 20 operational facilities. Sussex residents are diverse with varying healthcare needs. It employs a trained caregiving staff made up of individuals passionate about improving the lives of others. Some even look at some of the residents as extended family.
Sussex is interested in more than just making the people who call Sussex Healthcare facilities home comfortable. They try their best to make the lives of its residents worth living by providing them access to leisure, social, and recreational activities.
Read more: Sussex Healthcare’s New Facility Is As Amazing As Its Quality Of Care
About Sussex Leadership
Amanda Morgan-Taylor is the CEO of Sussex Healthcare. Though she was just recently named CEO people expect big things from her moving forward. She has years of past experience in the medical field to draw from. Her first career was that of a mental health nurse. So she knows firsthand the kind of challenges residents of Sussex may be facing.
Shiraz Boghani is a successful entrepreneur and co-chair of Sussex. Before coming to Sussex Shiraz was a prominent hotel manager. In fact, just two years ago he was named Asian Business Awards Hotelier of the Year.
Search more about Sussex Healthcare: http://www.sussexhealthcare.org/sussex-health-care.html
Dr. Scott M. Rocklage is not new to healthcare management. The managing partner of 5 AM Ventures has been in the industry from the 70s, holding executive positions in several healthcare organizations. One of his greatest achievements in the industry was achieving the approval of Omniscan™, Cubicin®, and Teslascan® drugs by FDA. This achievement earned him lots of respect across the board, especially given the challenges that come with such approval.
Before joining 5 AM Ventures in 2003, Dr. Scott Rocklage had worked as CEO at Cubist Pharmaceuticals and Nycomed Salutar. He also had the chance to sit on the boards of management for Novira and Relypsa where he at some point served as chairman. Firms, such as Semprus, Miikana, and Ilypsa, also had hired Scott as their executive director in different times. Currently, he has a board membership for Rennovia Pulmatrix and Kinestral among others.
Dr. Scott is a highly qualified scientist, especially in the field of chemistry. His peer-reviewed publications are more than 30 while the patents associated with him are more than 100. He was privileged to attend his Ph.D. class at Massachusetts Institute of Technology (MIT) where his research supervisor was Prof. Richard R. Schrock. Prof. Richard is known for his immense contribution to the field of chemistry that led to his Nobel Prize win. Prior to the Ph.D., he had completed his bachelor’s at the University of California, Berkeley.
Scott is also respected by many for his philanthropic nature. He recently funded the renovation of laboratories at his alma mater, MIT department of chemistry.
Ideamensch featured Dr. Scott recently in an interview. He revealed that 5 AM Ventures derived its name from the word early, given that the organization is an early stage venture capital firm. He also revealed that much of his time is dedicated to the study of life science, although he spares a few hours to attend board meetings. At the office, he mostly rubs shoulders with scientists who seek his guidance on how to develop their research. Business executives also visit his office in search of medical knowledge that would help them grow their entrepreneurship within the pharmaceutical industry.